CV Sciences (CVSI) Retained Earnings (2010 - 2026)
CV Sciences (CVSI) posted Retained Earnings of $32000.0 for Q1 2026, down 99.96% sequentially from $89.3 million in Q4 2025, and up 146.15% YoY from $13000.0 in Q1 2025.
CV Sciences (CVSI) Retained Earnings (2010 - 2026) Analysis & Trends
CV Sciences has reported Retained Earnings for 17 years, with the latest figure at $32000.0 in Q1 2026.
- Quarterly Retained Earnings rose 146.15% year-over-year to $32000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32000.0 (up 146.15% YoY) and the FY2025 annual result came in at $89.3 million, up 595633.33% from the prior year.
- Retained Earnings declined to $32000.0 in Q1 2026 per CVSI's latest filing, from $89.3 million in the prior quarter.
- Over five years, Retained Earnings peaked at $89.3 million in Q4 2025 and troughed at -$87.4 million in Q2 2025.
- A 5-year average of $1.6 million and a median of $5500.0 in 2024 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 595633.33% in 2025, down 4369900.0% in 2025.
- Over 5 years, Retained Earnings stood at $86.7 million in 2022, then sank by 197.53% to -$84.6 million in 2023, then surged by 99.98% to -$15000.0 in 2024, then soared by 595633.33% to $89.3 million in 2025, then slumped by 99.96% to $32000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $32000.0, $89.3 million, and $89.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 90.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.88 Mn |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 89.33 Mn |
| Sep 30, 2025 | 89.21 Mn |
| Jun 30, 2025 | -87.40 Mn |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | 88.41 Mn |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 87.56 Mn |
| Dec 31, 2023 | -84.59 Mn |
| Sep 30, 2023 | 87.18 Mn |
| Jun 30, 2023 | -83.30 Mn |
| Mar 31, 2023 | -81.98 Mn |
| Sep 30, 2022 | 86.73 Mn |
| Jun 30, 2022 | -84.30 Mn |
| Mar 31, 2022 | -81.70 Mn |
| Dec 31, 2021 | 83.01 Mn |
| Sep 30, 2021 | -70.62 Mn |
| Jun 30, 2021 | 80.54 Mn |